Corporacio Sanitaria Parc Tauli; Servicio de Hematologia

Sabadell, Barcelona 08208

0 studies enrolling now · 1 studies all time

What they study most

Non-Hodgkin's Lymphoma

Studies at this site

• A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM) — Completed